Albira Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
MFDS item code 201403813 · Approved 2014.08.19
This product's status changed to Expired on 2024.08.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.); prevention of Mendelson syndrome
This medication is used to treat gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, gastroesophageal reflux disease, and ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is also given to prevent Mendelson's syndrome prior to anesthesia and helps prevent ulcers that may occur after surgery. This drug protects the gastric mucosa and reduces acid secretion, thereby improving symptoms. Therefore, it is effectively used for the treatment and prevention of various gastrointestinal disorders.
○ Adults Usually, regardless of meals, administer 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drug use or to prevent gastric and duodenal ulcers during long-term nonsteroidal anti-inflammatory drug use. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome As the initial dose, begin treatment with 2 tablets 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used in patients receiving dialysis treatment or those who have had an allergic reaction to this medication or its components. It is also advisable not to administer it to patients with a history of acute porphyria, those with impaired renal function, those who have undergone gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, and newborns, and patients on a potassium-restricted diet. Patients with liver dysfunction, those who have had hypersensitivity reactions to drugs, the elderly, those with a history of renal impairment, and patients taking NSAIDs should be closely monitored while using this medication. It can conceal symptoms of stomach cancer, so patients with gastric ulcers or middle-aged or older patients who have newly developed or changed dyspeptic symptoms must verify the possibility of malignancy before taking it. Patients with gastric or duodenal ulcers infected with Helicobacter pylori must also undergo treatment to eradicate the bacteria. Special care is needed for patients in severe intensive care units, those with hypophosphatemia, and those who have difficulty swallowing. Rarely, serious allergic reactions, skin rashes, blood abnormalities, liver dysfunction, cardiac arrhythmias, digestive disorders, and neurological symptoms may occur during the use of this medication, so if any abnormal symptoms occur, it is important to consult a doctor immediately. If there is no therapeutic effect without long-term use, it is preferable to switch to another medication, and it is important to have regular blood tests and assess liver and kidney function. Elderly patients or those with chronic lung diseases, diabetes, or weakened immune systems may have an increased risk of pneumonia while taking this medication, so caution is required. If dizziness or drowsiness occurs while taking this medication, it is advised to avoid driving or operating hazardous machinery. This medication can affect the absorption or metabolism of other drugs; therefore, if taking other medications, it is essential to inform your doctor or pharmacist, especially when taken with anticoagulants or antibiotics. It is safest not to use this medication during pregnancy or while breastfeeding, and safety in pediatric patients has not been established, so it is advisable not to administer it. In cases of overdose, emergency treatments such as vomiting or gastric lavage may be necessary; in some cases, hemodialysis may be helpful. This medication reduces gastric acid secretion, which may promote bacterial growth in the stomach; therefore, it is advised to have an eye examination during long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, preferably at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication.
White, round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride · Tripotassium Bismuth Dicitrate +1 more
Prescription medication · Combination
Hankook Hyutex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.